Lam Research Corporation $LRCX Shares Acquired by Capital Investment Advisors LLC

Capital Investment Advisors LLC lifted its holdings in Lam Research Corporation (NASDAQ:LRCX) by 6.9% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 49,937 shares of the semiconductor company’s stock after purchasing an additional 3,226 shares during the period. Capital Investment Advisors LLC’s holdings in Lam Research were worth $6,687,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. IMG Wealth Management Inc. acquired a new position in shares of Lam Research in the second quarter worth $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research in the second quarter valued at $27,000. Strategic Wealth Investment Group LLC purchased a new position in Lam Research in the second quarter valued at $29,000. Delos Wealth Advisors LLC acquired a new position in Lam Research during the 2nd quarter worth $30,000. Finally, REAP Financial Group LLC purchased a new stake in Lam Research during the 2nd quarter worth about $31,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Lam Research

In other news, Director Bethany Mayer sold 1,298 shares of the stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares in the company, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 102,608 shares of company stock worth $14,916,496 in the last three months. Corporate insiders own 0.31% of the company’s stock.

Analysts Set New Price Targets

LRCX has been the subject of a number of analyst reports. TD Cowen boosted their price objective on Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Berenberg Bank boosted their price target on shares of Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Barclays set a $142.00 price objective on shares of Lam Research and gave the company an “equal weight” rating in a research report on Monday, October 20th. New Street Research lifted their price objective on shares of Lam Research from $105.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Finally, Hsbc Global Res upgraded shares of Lam Research to a “hold” rating in a research note on Tuesday, September 30th. Twenty-six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat, Lam Research currently has a consensus rating of “Moderate Buy” and an average price target of $163.04.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Multiple analysts and research notes are highlighting Lam’s exposure to AI chipmaking tools, helping drive the recent multi-day rally and raising investor appetite. Lam Research Is Up 19.1% After Analysts Spotlight Its AI-Focused Chipmaking Tools
• Positive Sentiment: Comparative analyst coverage gives Lam an edge versus peers (e.g., TSM), citing steadier growth and stronger positioning in the AI equipment cycle. LRCX vs. TSM: Which Semiconductor Powerhouse Is the Better Buy?
• Positive Sentiment: High-profile endorsements and buy ratings (including visible media mentions) have amplified investor interest and momentum. Jim Cramer notes that Lam Research is one of the stocks he likes so much
• Neutral Sentiment: Lam set a public date for its December-quarter earnings conference call on Jan. 28 — a key event that should clarify near-term demand and margins. Lam Research Corporation Announces December Quarter Financial Conference Call
• Neutral Sentiment: Some firms updated or reissued ratings (Aletheia Capital noted a new rating), which can change short-term flows but didn’t by itself set a clear positive/negative bias. Lam Research Receives a New Rating from Aletheia Capital
• Negative Sentiment: Significant insider selling has been reported (multiple executives sold shares), which may raise governance or timing concerns for some investors. Lam Research Stock Opinions on Recent ‘Buy’ Rating and AI Demand
• Negative Sentiment: Analysts and commentators warn about valuation risk after the steep run-up — rapid gains can lead to sharp pullbacks if macro or demand signals soften. As Lam Research Surges, Here Is The Risk You Should Know
• Negative Sentiment: The stock has shown short-term volatility and recently dipped more than the broader market on profit-taking and rotation. Why Lam Research (LRCX) Dipped More Than Broader Market Today

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $200.96 on Friday. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $210.45. The firm has a market capitalization of $252.41 billion, a P/E ratio of 44.26, a P/E/G ratio of 2.34 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The company’s fifty day moving average price is $164.77 and its 200 day moving average price is $131.92.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same quarter last year, the company posted $0.86 earnings per share. The business’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd were given a dividend of $0.26 per share. The ex-dividend date of this dividend was Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.5%. Lam Research’s payout ratio is 22.91%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.